FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
|
With this approval, flibanserin becomes the first and only
treatment of its kind for women younger than 65 years. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
|
With this approval, flibanserin becomes the first and only
treatment of its kind for women younger than 65 years. |